Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers, 2021, Neda Stjepanovic , Jan Lubiński , Pal Moller , Susan Randall Armel , William D. Foulkes , Nadine Tung , Susan L. Neuhausen , Joanne Kotsopoulos , Ping Sun , Sophie Sun , Andrea Eisen , Steven A. Narod , Breast Cancer Research and Treatment, Vol. 187, Iss. 2, 515--523, ISSN: 0167-6806, eISSN: 1573-7217, bibliogr. rys. summ.
Słowa kluczowe: BRCA1, BRCA2, Incidence, Prospective
Kod: CZR-N-WYKAZ BibTeX (pkt. 140) DOI: 10.1007/s10549-020-06072-9

Allelic modification of breast cancer risk in women with an NBN mutation, 2019, Bogna Rusak , Wojciech Kluźniak , Dominika Wokołorczyk , Klaudia Stempa , Aniruddh Kashyap , Helena Rudnicka , Jacek Gronwald , Tomasz Huzarski , Tadeusz Dębniak , Anna Jakubowska , Marek Szwiec , Mohammad R Akbari , Steven A. Narod , Jan Lubiński , Cezary Cybulski , the Polish Hereditary Breast Cancer Consortium , Breast Cancer Research and Treatment, Vol. 178, Iss. 2, 427--431, ISSN: 0167-6806, eISSN: 1573-7217, bibliogr. tab. summ.
Słowa kluczowe: Breast cancer, Mutation, NBN, NBS1
Kod: CZR-N-WYKAZ BibTeX (pkt. 140) DOI: 10.1007/s10549-019-05391-w

Open Access: Licence: CC-BY, Article mode: OPEN_JOURNAL, Release time: AT_PUBLICATION, Text version: FINAL_PUBLISHED, Date of publication: 13-08-2019

Inherited variants in XRCC2 and the risk of breast cancer, 2019, Wojciech Kluźniak , Dominika Wokołorczyk , Bogna Rusak , Tomasz Huzarski , - [et al.] , Marek Szwiec , - [et al.] , Breast Cancer Research and Treatment, 2019, 1--7, ISSN: 0167-6806, eISSN: 1573-7217,
Słowa kluczowe: Breast cancer, Hereditary, Mutation, XRCC2
Kod: CZR-N-WYKAZ BibTeX (pkt. 140) DOI: 10.1007/s10549-019-05415-5

Predictors of survival for breast cancer patients with a BRCA1 mutation, 2018, Steven A. Narod , Tomasz Huzarski(*) , Jacek Gronwald , Tomasz Byrski , Elżbieta Marczyk , Cezary Cybulski , Marek Szwiec , Rafał Wiśniowski , Bożena Birkenfeld , Ewa Kilar , Robert Sibilski , Ping Sun , Jan Lubiński , Breast Cancer Research and Treatment, 168 (2), 513--521, ISSN: 0167-6806, eISSN: 1573-7217, bibliogr. summ.
Słowa kluczowe: BRCA1, Breast cancer, Cisplatinum, Oophorectomy, Survival
Kod: CZR-JCR BibTeX (pkt. 35) DOI: 10.1007/s10549-017-4605-x

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer, 2012, Tomasz Byrski , Rebecca Dent , Paweł Blecharz , Małgorzata Foszczyńska-Kloda , Jacek Gronwald , Tomasz Huzarski(*) , Cezary Cybulski , Elżbieta Marczyk , Robert Chrzan , Andrea Eisen , Jan Lubiński , Steven A. Narod , Breast Cancer Research, 14, 110, 1--8, ISSN: 1465-5411, eISSN: 1465-542X,
Kod: CZR-JCR BibTeX (pkt. 40) DOI: 10.1186/bcr3231